Abstract: The multifunctional and smart stop-sign device is a device intended to provide connectivity, security, alerts, notices etc. based on a specific range of operation. Accordingly, the device is a mobile stop-sign device that may be dispatched to environmentally impacted communities to function as a beacon for security, connectivity and environmental notices. In this use the device would only be a temporary sign installed for the benefit of assisting impacted communities in their recovery efforts. To accomplish this the device includes a stop-sign symbol with an enclosure that contains an electrical and electronic system and a power device. Further, the device may be solar powered, may record suspicious activities, highlight suspicious vehicles and provide backup Wi-Fi in the event of a power shortage and perform many other functions. Furthermore, the device includes satellite connectivity that helps with GPS positioning services/alerts as well as surveillance related services.

Abstract: A system for facilitating interactions via digital representations using artificial intelligence is provided. The system generates and renders a digital representation associated with a provider that interacts with a user, such as via a user interface of a computer application. Information obtained via the interactions, along with sensor data, is provided to an artificial intelligence engine supporting the functionality of the digital representation to predict a medical complaint of the user, predict an assessment and/or diagnosis for the user, predict a treatment plan for treating the medical complaint and/or diagnosis, and generate a digital record for the user. If further review of the digital record is needed, the provider updates and finalizes the digital record. The artificial intelligence engine and supporting machine learning models are trained to enhance the digital representations, enhance future interactions with users using the digital representations, and enhance generation of digital records.

Abstract: A system for providing automated case management and reporting via artificial intelligence is provided. The system interacts with a user to obtain information from the user, which is then provided to an artificial intelligence engine to determine a medical complaint of the user. The artificial intelligence engine proceeds to automatically generate a digital record for the user that includes a predicted assessment and plan for treating the medical complaint. If standing order protocols exist, the digital records may be finalized and provided to the user, to a medical billing system, and to third parties for review and processing. Otherwise, the system may provide the digital record to a physician for further review to confirm the predictions and information associated with the digital record or to update the digital record. The digital record is then finalized and reported to the user, the medical billing system, and other third parties.

Abstract: A system for facilitating routing to a provider via artificial intelligence is provided. The system interacts with a user to obtain information from the user during an encounter. The information is provided to an artificial intelligence engine to determine a medical complaint of the user. The artificial intelligence engine proceeds to generate a list of providers matching criteria associated with the medical complaint, the information, or a combination thereof. Additional filters are applied to the list of providers to enhance correlation of the providers in the list for the individual. The artificial intelligence engine determines an optimal provider from the list based on the optimal provider having a greater correlation with the information, the medical complaint, or a combination thereof, than other providers in the list. The system presents the list of providers and digital links to enable selection of one or more providers to establish connections with the providers.

Abstract: A system for utilizing artificial intelligence for facilitating physician assessment is provided. The system interacts with a user to obtain information from the user, which is then provided to an artificial intelligence engine to predict an assessment and generate a digital record for the user including a plan for the user. The engine compares the predicted assessment to standing order protocols and provider standards protocols to determine if there is a match. If there is a match, instructions according to the protocols are executed. Otherwise, the system places the digital record containing the assessment in a worklist for further review to determine a workflow for the assessment. The workflow instructs the user to proceed directly to an emergency room, schedule a consultation with a provider, or to have the assessment reviewed by a provider. The digital record is updated and provided to the user, third parties, and billing systems.

Abstract: A hot stick for manipulating a probe from a position a selected distance away from a workpiece, the tool including an arm, a connector coupled to the arm, the connector including a connector body having a contoured first surface, and a mechanism movable relative to the connector body and configured to cooperate with the first surface of the body to retain a probe.

Abstract: Therapeutically-effective amounts of novel analogs or derivatives of alkyl fatty, acids, such as but not limited to lipoic acid, and pharmaceutical formulations comprising such analogs or derivatives and pharmaceutically-acceptable carriers therefor, are useful for the treatment, prevention, imaging, and/or diagnosis of medical disorders.

Abstract: Therapeutically-effective amounts of novel analogs or derivatives of alkyl fatty acids, such as but not limited to lipoic acid, and pharmaceutical formulations comprising such analogs or derivatives and pharmaceutically-acceptable carriers therefor, are useful for the treatment, prevention, imaging, and/or diagnosis of medical disorders.

Abstract: Therapeutically-effective amounts of novel analogs or derivatives of alkyl fatty acids, such as but not limited to lipoic acid, and pharmaceutical formulations comprising such analogs or derivatives and pharmaceutically-acceptable carriers therefor, are useful for the treatment, prevention, imaging, and/or diagnosis of medical disorders.

Abstract: The present disclosure relates to methods and systems for delivering and presenting notifications at a consumer device. The method includes receiving, by a notification manager, from a client device, a notification to be delivered to an application executing on a consumer device. The method also includes holding, by the notification manager, the notification in a notification queue. The method further includes identifying, by the notification manager, a consumer notification policy of the consumer device applicable to the notification, the consumer notification policy specifying one or more conditions for presenting the notification at the consumer device. The method further includes releasing, by the notification manager, from the notification queue, the notification for presentation at the consumer device upon determining that the conditions of the consumer notification policy have been met.

Abstract: Therapeutically-effective amounts of novel analogs or derivatives of alkyl fatty acids, such as but not limited to lipoic acid, and pharmaceutical formulations comprising such analogs or derivatives and pharmaceutically-acceptable carriers therefor, are useful for the treatment, prevention, imaging, and/or diagnosis of medical disorders.

Abstract: A hot stick for manipulating a probe from a position a selected distance away from a workpiece, the tool including an arm, a connector coupled to the arm, the connector including a connector body having a contoured first surface, and a mechanism movable relative to the connector body and configured to cooperate with the first surface of the body to retain a probe.

Abstract: Therapeutically-effective amounts of novel analogs or derivatives of alkyl fatty acids, such as but not limited to lipoic acid, and pharmaceutical formulations comprising such analogs or derivatives and pharmaceutically-acceptable carriers therefor, are useful for the treatment, prevention, imaging, and/or diagnosis of medical disorders.

Abstract: Therapeutically-effective amounts of novel analogs or derivatives of alkyl fatty, acids, such as but not limited to lipoic acid, and pharmaceutical formulations comprising such analogs or derivatives and pharmaceutically-acceptable carriers therefor, are useful for the treatment, prevention, imaging, and/or diagnosis of medical disorders.

Abstract: According to aspects of the present disclosure, the present disclosure describes methods and systems for collecting, managing and using subscriber information. A communications technology platform can establish interfaces through which subscribers allow the subscriber information management system to retrieve subscriber information from a plurality of content sources and store the retrieved subscriber information in one or more databases. These content sources can include the subscriber's devices, one or more social networking platforms to which the subscriber belongs, mobile phone service carriers, third-party applications or websites with which the subscriber is capable of receiving subscriber information from, amongst others. The databases of the communication platform can be configured to store subscriber records that include subscriber information pertaining to each subscriber.

Abstract: The present disclosure relates to methods and systems for delivering and presenting notifications at a consumer device. The method includes receiving, by a notification manager, from a client device, a notification to be delivered to an application executing on a consumer device. The method also includes holding, by the notification manager, the notification in a notification queue. The method further includes identifying, by the notification manager, a consumer notification policy of the consumer device applicable to the notification, the consumer notification policy specifying one or more conditions for presenting the notification at the consumer device. The method further includes releasing, by the notification manager, from the notification queue, the notification for presentation at the consumer device upon determining that the conditions of the consumer notification policy have been met.

Abstract: Therapeutically-effective amounts of novel analogs or derivatives of alkyl fatty acids, such as but not limited to lipoic acid, and pharmaceutical formulations comprising such analogs or derivatives and pharmaceutically-acceptable carriers therefor, are useful for the treatment, prevention, imaging, and/or diagnosis of medical disorders.